Average Medical Expenditures by Sector for COVID-19 Patients without Hypertension and/or Diabetes with Initial COVID-19 Hospitalization and COVID-19 Diagnosis but No Hospitalization
| Unmatched | Matched Treatment Effect | ||||
|---|---|---|---|---|---|
| Case Subjects $ | Control Subjects $ | Difference $ | Control | Difference | |
| (n) | (n) | (%) | Subjects $ | $ | |
| Outpatient services | |||||
| 30 days | 5,844 (2682) | 2,593 (262,787) | 3,250 (77) | 3,000 | 2,844*** (64) |
| 60 days | 5,911 (2003) | 2,367 (212,770) | 3,543 (86) | 2,960 | 2,951*** (67) |
| 120 days | 4,493 (1377) | 1,757 (135,603) | 2,737 (88) | 2,329 | 2,164*** (63) |
| Inpatient admissions and services | |||||
| 30 days | 74,255 (242) | 44,618 (3591) | 29,637 (50) | 45,852 | 28,403** (47) |
| 60 days | 82,144 (144) | 43,482 (2710) | 28,662 (62) | 49,138 | 33,006* (50) |
| 120 days | 63,409 (75) | 40,436 (1343) | 22,972 (44) | 49,595 | 13,814 (24) |
| Pharmaceuticals | |||||
| 30 days | 2,035 (2113) | 1,410 (200,106) | 625 (36) | 1,614 | 421* (23) |
| 60 days | 1,923 (1637) | 1,306 (161,662) | 617 (38) | 1,539 | 384* (22) |
| 120 days | 1,475 (1128) | 1,004 (101,570) | 471 (38) | 1.191 | 284 (21) |
| Total | |||||
| 30 days | 13,317 (2849) | 3,832 (293,260) | 9,486 (111) | 4,690 | 8,627*** (96) |
| 60 days | 12,283 (2183) | 3,498 (238,012) | 8,786 (111) | 4,327 | 7,956*** (96) |
| 120 days | 8,175 (1542) | 2,533 (155,717) | 5,641 (105) | 3,380 | 4,795*** (83) |
Notes: Statistical significance (*P < .05, **P < .01, ***P < .001) using z-score; All spending is assessed 30, 60 or 120 days after the COVID-19 index data till the end of the calendar year.